Life sciences update - October 2020

Life sciences update - October 2020

Life Sciences update - October 2020

We bring you our round-up of the latest legal and commercial issues for life sciences businesses.

As we approach the end of the Brexit transition period, we cover two key issues for businesses in the sector: mutual recognition agreements and changes to the immigration regime. We also give a legal overview of two key industry terms: marketing authorisation and medical devices, and look at the new arbitration rules recently introduced by the LCIA.

A link to the web version of this email update is available here. If you would like to receive these updates via email, please subscribe.


Contact our experts for further advice

Search our site